Case and Research Letter
Cutaneous Apocrine Adenocarcinoma of the Groin With Extramammary Paget Disease: Response to Dual HER2 Blockade With Trastuzumab and Pertuzumab
Adenocarcinoma apocrino cutáneo inguinal con enfermedad de Paget extramamaria: respuesta a bloqueo dual HER2 con trastuzumab y pertuzumab
Read
3457
Timeswas read the article
1141
Total PDF
2316
Total HTML
Share statistics
array:25 [ "pii" => "S0001731022008341" "issn" => "00017310" "doi" => "10.1016/j.ad.2022.10.012" "estado" => "S300" "fechaPublicacion" => "2022-11-01" "aid" => "3233" "copyright" => "AEDV" "copyrightAnyo" => "2021" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2022;113:T973-T975" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:18 [ "pii" => "S0001731022003350" "issn" => "00017310" "doi" => "10.1016/j.ad.2021.07.021" "estado" => "S300" "fechaPublicacion" => "2022-11-01" "aid" => "3036" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2022;113:976-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta científico-clínica</span>" "titulo" => "Queilitis glandular. ¿Una entidad rara o infradiagnosticada?" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "976" "paginaFinal" => "977" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Glandular Cheilitis: Rare or Underdiagnosed?" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figura 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1341 "Ancho" => 1505 "Tamanyo" => 658390 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Histología (H&E, ×20): A) Glándulas salivares menores con dilatación ductal. B y C) Se objetivan imágenes de metaplasia escamosa y células plasmáticas en el intersticio glandular. D) En el interior de las luces se podía observar un material compacto, que se extendía hacia la superficie y era PAS positivo.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "R. García Castro, L. Revelles Peñas, M. Roncero Riesco, E. Godoy Gijón" "autores" => array:4 [ 0 => array:2 [ "nombre" => "R." "apellidos" => "García Castro" ] 1 => array:2 [ "nombre" => "L." "apellidos" => "Revelles Peñas" ] 2 => array:2 [ "nombre" => "M." "apellidos" => "Roncero Riesco" ] 3 => array:2 [ "nombre" => "E." "apellidos" => "Godoy Gijón" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022003350?idApp=UINPBA000044" "url" => "/00017310/0000011300000010/v1_202211300529/S0001731022003350/v1_202211300529/es/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S0001731021004178" "issn" => "00017310" "doi" => "10.1016/j.ad.2021.04.010" "estado" => "S300" "fechaPublicacion" => "2022-11-01" "aid" => "2808" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2022;113:973-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENTÍFICO-CLÍNICA</span>" "titulo" => "Adenocarcinoma apocrino cutáneo inguinal con enfermedad de Paget extramamaria: respuesta a bloqueo dual HER2 con trastuzumab y pertuzumab" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "973" "paginaFinal" => "975" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Cutaneous Apocrine Adenocarcinoma of the Groin With Extramammary Paget Disease: Response to Dual HER2 Blockade With Trastuzumab and Pertuzumab" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 3959 "Ancho" => 1508 "Tamanyo" => 585220 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A) Masa ulcerada en ingle izquierda adherida a planos profundos de 8 x 9<span class="elsevierStyleHsp" style=""></span>cm. B) Reducción significativa de la masa a las 8 semanas de tratamiento con bloqueo dual HER2.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. Sola-Ortigosa, C. Muñoz-Santos, M. Hernández-Bronchud, A. Guilabert-Vidal" "autores" => array:4 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Sola-Ortigosa" ] 1 => array:2 [ "nombre" => "C." "apellidos" => "Muñoz-Santos" ] 2 => array:2 [ "nombre" => "M." "apellidos" => "Hernández-Bronchud" ] 3 => array:2 [ "nombre" => "A." "apellidos" => "Guilabert-Vidal" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731021004178?idApp=UINPBA000044" "url" => "/00017310/0000011300000010/v1_202211300529/S0001731021004178/v1_202211300529/es/main.assets" ] "asociados" => array:1 [ 0 => array:19 [ "pii" => "S0001731021004178" "issn" => "00017310" "doi" => "10.1016/j.ad.2021.04.010" "estado" => "S300" "fechaPublicacion" => "2022-11-01" "aid" => "2808" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2022;113:973-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENTÍFICO-CLÍNICA</span>" "titulo" => "Adenocarcinoma apocrino cutáneo inguinal con enfermedad de Paget extramamaria: respuesta a bloqueo dual HER2 con trastuzumab y pertuzumab" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "973" "paginaFinal" => "975" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Cutaneous Apocrine Adenocarcinoma of the Groin With Extramammary Paget Disease: Response to Dual HER2 Blockade With Trastuzumab and Pertuzumab" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 3959 "Ancho" => 1508 "Tamanyo" => 585220 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A) Masa ulcerada en ingle izquierda adherida a planos profundos de 8 x 9<span class="elsevierStyleHsp" style=""></span>cm. B) Reducción significativa de la masa a las 8 semanas de tratamiento con bloqueo dual HER2.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. Sola-Ortigosa, C. Muñoz-Santos, M. Hernández-Bronchud, A. Guilabert-Vidal" "autores" => array:4 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Sola-Ortigosa" ] 1 => array:2 [ "nombre" => "C." "apellidos" => "Muñoz-Santos" ] 2 => array:2 [ "nombre" => "M." "apellidos" => "Hernández-Bronchud" ] 3 => array:2 [ "nombre" => "A." "apellidos" => "Guilabert-Vidal" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731021004178?idApp=UINPBA000044" "url" => "/00017310/0000011300000010/v1_202211300529/S0001731021004178/v1_202211300529/es/main.assets" ] ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>" "titulo" => " Cutaneous Apocrine Adenocarcinoma of the Groin With Extramammary Paget Disease: Response to Dual HER2 Blockade With Trastuzumab and Pertuzumab" "tieneTextoCompleto" => true "saludo" => "To the Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "T973" "paginaFinal" => "T975" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "J. Sola-Ortigosa, C. Muñoz-Santos, M. Hernández-Bronchud, A. Guilabert-Vidal" "autores" => array:4 [ 0 => array:4 [ "nombre" => "J." "apellidos" => "Sola-Ortigosa" "email" => array:1 [ 0 => "quimsola@yahoo.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "C." "apellidos" => "Muñoz-Santos" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "M." "apellidos" => "Hernández-Bronchud" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 3 => array:3 [ "nombre" => "A." "apellidos" => "Guilabert-Vidal" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Department of Dermatology, Fundació Privada Hospital Asil de Granollers, Barcelona, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "GenesisCare Corachan Clinic, Barcelona, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Adenocarcinoma apocrino cutáneo inguinal con enfermedad de Paget extramamaria: respuesta a bloqueo dual HER2 con trastuzumab y pertuzumab" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2265 "Ancho" => 902 "Tamanyo" => 229174 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A, Ulcerated left inguinal mass measuring 8<span class="elsevierStyleHsp" style=""></span>cm<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>9<span class="elsevierStyleHsp" style=""></span>cm fixed to the deep planes. B, Significant reduction in size after 8 weeks of dual HER2 blockade.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Cutaneous apocrine carcinoma is a rare malignant tumor with a poor prognosis.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a> Invasive extramammary Paget disease (EMPD) is an uncommon form of adenocarcinoma that mainly arises in the area of the apocrine glands; it has a worse prognosis than EMPD in situ and a higher risk of underlying malignancy.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a> Pagetoid epidermal spread is rare in apocrine carcinoma.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a> Very few cases have been described and the histogenesis is unknown.<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">2–5</span></a> HER2/neu (c-erbB-2) is overexpressed in approximately 20% to 60% of EMPD cases, and few patients have responded favorably to the recombinant anti-HER2 monoclonal antibody trastuzumab, either alone or in combination with paclitaxel.<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">2,3</span></a> As occurs in HER2-positive breast cancer, overexpression of HER2/neu in EMPD leads to increased tumor cell proliferation and is associated with more aggressive behavior and more recurrences.<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">2,4</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">We describe the case of a patient with invasive metastatic apocrine adenocarcinoma and inguinal EMPD who showed a near-complete response to dual HER2 blockade (trastuzumab and pertuzumab) that enabled him to undergo salvage surgery.</p><p id="par0015" class="elsevierStylePara elsevierViewall">An 80-year-old man presented with a 9-cm left inguinal mass of 8 months’ duration that was fixed to the deep planes (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>A). He was on multiple medications and had a history of hypertension, diabetes mellitus, ischemic heart disease, chronic heart failure, atrial fibrillation, chronic renal failure, and morbid obesity. Microscopic examination of a partial biopsy specimen showed features suggestive of Paget cells: atypical polygonal cells with round nuclei and clear granular cytoplasm at the dermal-epidermal junction (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>A). In the dermis, there was a well-circumscribed, nonencapsulated tumor nodule with dilated lumina and a nested tubular-cribriform pattern (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>B). The tumor cells were pleomorphic and had a granular eosinophilic cytoplasm with apocrine-like changes, significant mitotic activity, and comedonecrosis. The cells stained diffusely for cytokeratin (CK) 7, CAM5.2, GATA3, carcinoembryonic antigen; focally for Ber-EP4; and negatively for CK20, MART-1, prostate-specific antigen, uroplakin-III, and S100 protein, confirming their apocrine nature. HER2/neu was also expressed in 90% of the tumor cells. These findings were consistent with adnexal apocrine adenocarcinoma and cutaneous EMPD. Magnetic resonance imaging showed a heterogeneous tumor measuring 8<span class="elsevierStyleHsp" style=""></span>cm<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>9<span class="elsevierStyleHsp" style=""></span>cm in the left groin with invasion of the dermis and subcutaneous tissue. Also visible were enlarged left inguinal and retroperitoneal metastatic lymph nodes. No breast lesions or other primary malignant lesions were found on positron emission tomography. Due to the unresectable, inoperable nature of the tumor, it was decided to administer palliative treatment with compassionate use of dual HER2 blockade with trastuzumab and pertuzumab as an alternative to potentially more toxic chemotherapy. The dosing regimen was a standard regimen used in metastatic breast cancer (subcutaneous trastuzumab at a fixed dose of 600<span class="elsevierStyleHsp" style=""></span>mg every 21 days and intravenous pertuzumab with a loading dose of 840<span class="elsevierStyleHsp" style=""></span>mg followed by 420<span class="elsevierStyleHsp" style=""></span>mg every 3 weeks).<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">6</span></a> The treatment was well tolerated. Regular echocardiographic assessment of left ventricular function showed no evidence of dysfunction. By the end of the third cycle, the mass had almost completely resolved (reduction of 7<span class="elsevierStyleHsp" style=""></span>cm) (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>B). MRI also showed normal-sized lymph nodes. This favorable response enabled complete excision of the residual tumor with negative margins. No recurrences were observed over 12 months of follow-up.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0020" class="elsevierStylePara elsevierViewall">Just 6 cases of cutaneous apocrine carcinoma and inguinal EMDP have been described to date.<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1–3</span></a> Distinguishing between cutaneous apocrine adenocarcinoma and metastatic mammary apocrine carcinoma in the skin can be difficult because of overlapping histopathologic and immunohistochemical features.<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">4</span></a> Clinically, cutaneous apocrine carcinoma and EMPD typically appear as an isolated mass in the apocrine areas (axilla, groin, scrotum, or perineal region) in patients aged between 46 and 82 years.<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1–5</span></a> They are locally aggressive and frequently spread to the regional lymph nodes (30%–60% of all cases).<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1–5</span></a> HER2/neu expression in Paget cells is associated with a poor prognosis in EMPD, but it also has therapeutic implications.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a> A deep biopsy prior to surgery is required to assess depth of tissue invasion and rule out an underlying apocrine adenocarcinoma. The treatment of choice is wide surgical excision with regional lymph node dissection.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">7</span></a> Due to the rareness of this entity, there is no consensus regarding pharmacologic treatments. Both chemotherapy and hormone therapy have been shown to be ineffective.<a class="elsevierStyleCrossRefs" href="#bib0085"><span class="elsevierStyleSup">7–9</span></a> In HER2-positive metastatic breast cancer, by contrast, pertuzumab combined with trastuzumab and docetaxel is associated with longer progression-free survival than trastuzumab plus docetaxel or paclitaxel alone.<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">8,9</span></a> Apocrine cutaneous glands are likely evolutionary precursors of mammary glands and could share HER2/neu pharmacological targets.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">We have described for the first time the use of neoadjuvant dual blockade to treat metastatic EMPD with an underlying apocrine adenocarcinoma. This treatment can be considered in selected patients, as there are no approved standard treatment regimens available to treat locally advanced, unresectable disease. This case illustrates the need to perform deep biopsies and evaluate HER2/neu expression in all cases of metastatic or invasive EMPD in order to determine the possibility of dual HER2 blockade with monoclonal antibodies as neoadjuvant therapy before surgery.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicts of Interest</span><p id="par0030" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflicts of Interest" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:2 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2265 "Ancho" => 902 "Tamanyo" => 229174 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A, Ulcerated left inguinal mass measuring 8<span class="elsevierStyleHsp" style=""></span>cm<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>9<span class="elsevierStyleHsp" style=""></span>cm fixed to the deep planes. B, Significant reduction in size after 8 weeks of dual HER2 blockade.</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1387 "Ancho" => 891 "Tamanyo" => 443055 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A, Intraepithelial proliferation of large, round, pale cells (Paget cells) dispersed through the epidermis with basophilic cytoplasm and enlarged central nuclei with nuclear atypia (hematoxylin-eosin, original magnification ×40). B, Underlying adenocarcinoma cells with mild nuclear pleomorphism. Note the deep invasion of the subcutaneous tissue and the nest and tubule arrangement (hematoxylin-eosin, original magnification ×100).</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:10 [ 0 => array:3 [ "identificador" => "bib0055" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Primary cutaneous apocrine carcinoma: a clinico-pathologic analysis of 24 cases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Robson" 1 => "A.J. Lazar" 2 => "J. Ben Nagi" 3 => "A. Hanby" 4 => "W. Grayson" 5 => "M. Feinmesser" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Surg Pathol" "fecha" => "2008" "volumen" => "32" "paginaInicial" => "682" "paginaFinal" => "690" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0060" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Her-2/neu expression in extramammary Paget disease: a clinicopathologic and immunohistochemistry study of 47 cases with and without underlying malignancy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.A. Plaza" 1 => "C. Torres-Cabala" 2 => "D. Ivan" 3 => "V.G. Prieto" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Cut Path" "fecha" => "2009" "volumen" => "36" "paginaInicial" => "729" "paginaFinal" => "733" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0065" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Apocrine carcinoma of the groin possibly associated with extramammary Paget's disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S.H. Seo" 1 => "D.H. Shin" 2 => "H.W. Sung" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Dermatol" "fecha" => "2011" "volumen" => "23" "paginaInicial" => "519" "paginaFinal" => "522" "itemHostRev" => array:3 [ "pii" => "S0085253815460454" "estado" => "S300" "issn" => "00852538" ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0070" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Extramammary Paget's disease – evidence for an apocrine origin. An immunoperoxidase study of gross cystic disease fluid protein-15, carcinoembryonic antigen, and keratin proteins" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "G. Mazoujian" 1 => "G.S. Pinkus" 2 => "D.E. Haagensen Jr." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Surg Pathol" "fecha" => "1984" "volumen" => "8" "paginaInicial" => "43" "paginaFinal" => "50" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/6198933" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0075" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Depth and patterns of adnexal involvement in primary Extramammary (anogenital) Paget Disease: a study of 178 lesions from 146 patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.M. Konstantinova" 1 => "K.V. Shelekhova" 2 => "C.J. Stewart" 3 => "D.V. Spagnolo" 4 => "H. Kutzner" 5 => "D. Kacrovska" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/DAD.0000000000000552" "Revista" => array:6 [ "tituloSerie" => "Am J Dermatopathol" "fecha" => "2016" "volumen" => "38" "paginaInicial" => "802" "paginaFinal" => "808" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26863064" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0080" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Baselga" 1 => "J. Cortes" 2 => "S.B. Kim" 3 => "S. Im" 4 => "R. Hegg" 5 => "Y. Im" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa1113216" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2012" "volumen" => "366" "paginaInicial" => "109" "paginaFinal" => "119" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22149875" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0085" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A case of metastatic extramammary Paget's disease responding to trastuzumab plus paclitaxel combination therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "F. Hanawa" 1 => "T. Inozume" 2 => "K. Harada" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000333002" "Revista" => array:6 [ "tituloSerie" => "Case Rep Dermatol" "fecha" => "2011" "volumen" => "3" "paginaInicial" => "223" "paginaFinal" => "227" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22135629" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0090" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dramatic clinical response of relapsed metastatic extramammary Paget's disease to trastuzumab monotherapy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Wakabayashi" 1 => "Y. Togawa" 2 => "K. Yoneyama" 3 => "K. Suehiro" 4 => "N. Kambe" 5 => "H. Matsue" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Case Rep Dermatol Med" "fecha" => "2012" "volumen" => "3" "paginaInicial" => "401362" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0095" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Successful and long-term response to trastuzumab plus paclitaxel combination therapy in human epidermal growth factor receptor 2-positive extramammary Paget's disease: a case report and review of the literature" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Ichiyama" 1 => "D. Gomi" 2 => "T. Fukushima" 3 => "T. Kobayashi" 4 => "N. Sekiguchi" 5 => "A. Sakamoto" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3892/mco.2017.1422" "Revista" => array:6 [ "tituloSerie" => "Mol Clin Oncol" "fecha" => "2017" "volumen" => "7" "paginaInicial" => "763" "paginaFinal" => "766" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29181166" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0100" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Are aggressive epithelial cancers “a disease” of Eutherian mammals?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M.H. Bronchud" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3332/ecancer.2018.840" "Revista" => array:5 [ "tituloSerie" => "Ecancermedicalscience" "fecha" => "2018" "volumen" => "12" "paginaInicial" => "840" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30034517" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/00017310/0000011300000010/v1_202211300529/S0001731022008341/v1_202211300529/en/main.assets" "Apartado" => array:4 [ "identificador" => "6143" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Cartas científico-clínicas" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/00017310/0000011300000010/v1_202211300529/S0001731022008341/v1_202211300529/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022008341?idApp=UINPBA000044" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 15 | 15 | 30 |
| 2024 October | 123 | 55 | 178 |
| 2024 September | 130 | 45 | 175 |
| 2024 August | 123 | 59 | 182 |
| 2024 July | 85 | 44 | 129 |
| 2024 June | 101 | 55 | 156 |
| 2024 May | 70 | 44 | 114 |
| 2024 April | 87 | 36 | 123 |
| 2024 March | 68 | 41 | 109 |
| 2024 February | 51 | 47 | 98 |
| 2024 January | 105 | 42 | 147 |
| 2023 December | 88 | 36 | 124 |
| 2023 November | 42 | 37 | 79 |
| 2023 October | 96 | 53 | 149 |
| 2023 September | 78 | 33 | 111 |
| 2023 August | 78 | 21 | 99 |
| 2023 July | 103 | 46 | 149 |
| 2023 June | 78 | 30 | 108 |
| 2023 May | 79 | 32 | 111 |
| 2023 April | 50 | 33 | 83 |
| 2023 March | 89 | 34 | 123 |
| 2023 February | 75 | 41 | 116 |
| 2023 January | 83 | 59 | 142 |
| 2022 December | 183 | 73 | 256 |
| 2022 November | 125 | 54 | 179 |
| 2022 October | 111 | 76 | 187 |
Show all
